Notch2 signaling is required for potent antitumor immunity in vivo

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4673-4678

  Sugimoto, Koji ^a   Maekawa, Yoichi ^a   Kitamura, Akiko ^a   Nishida, Jun ^a   Koyanagi, Akemi ^b   Yagita, Hideo ^b   Kojima, Hidefumi ^c   Chiba, Shigeru ^d   Shimada, Mitsuo ^a   Yasutomo, Koji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; OVALBUMIN; GROWTH INHIBITOR; MONOCLONAL ANTIBODY; NOTCH1 PROTEIN, MOUSE; NOTCH2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; FLOW CYTOMETRY; IMMUNE RESPONSE; IN VIVO STUDY; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOMA; TRANSGENIC MOUSE; TUMOR IMMUNITY; ADOPTIVE IMMUNOTHERAPY; ANIMAL; C57BL MOUSE; CELL CULTURE; CHO CELL; CRICETULUS; CYTOTOXIC T LYMPHOCYTE; DRUG POTENTIATION; GENETICS; HAMSTER; IMMUNOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; GROWTH INHIBITORS; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; THYMOMA; THYMUS NEOPLASMS;

EID: 77954507341     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903661     Document Type: Article

References (19)

1. Zou, W., and L. Chen. 2008. Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8: 467-477.
2. Caspi, R. R. 2008. Immunotherapy of autoimmunity and cancer: the penalty for success. Nat. Rev. Immunol. 8: 970-976.
3. + regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194: 823-832.
4. Curiel, T. J., S. Wei, H. Dong, X. Alvarez, P. Cheng, P. Mottram, R. Krzysiek, K. L. Knutson, B. Daniel, M. C. Zimmermann, et al. 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9: 562-567.
5. Radtke, F., A. Wilson, S. J. Mancini, and H. R. MacDonald. 2004. Notch regulation of lymphocyte development and function. Nat. Immunol. 5: 247-253.
6. Maillard, I., T. Fang, andW. S. Pear. 2005. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu. Rev. Immunol. 23: 945-974.
7. Osborne, B. A., and L. M. Minter. 2007. Notch signalling during peripheral T-cell activation and differentiation. Nat. Rev. Immunol. 7: 64-75.
8. Maekawa, Y., Y. Minato, C. Ishifune, T. Kurihara, A. Kitamura, H. Kojima, H. Yagita, M. Sakata-Yanagimoto, T. Saito, I. Taniuchi, et al. 2008. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat. Immunol. 9: 1140-1147.
9. Kijima, M., T. Yamaguchi, C. Ishifune, Y. Maekawa, A. Koyanagi, H. Yagita, S. Chiba, K. Kishihara, M. Shimada, and K. Yasutomo. 2008. Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc. Natl. Acad. Sci. USA 105: 7010-7015.
10. Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18: 675-685.
11. + T cells. Immunity 19: 549-559.
12. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066.
13. Tagami, S., M. Okochi, K. Yanagida, A. Ikuta, A. Fukumori, N. Matsumoto, Y. Ishizuka-Katsura, T. Nakayama, N. Itoh, J. Jiang, et al. 2008. Regulation of Notch signaling by dynamic changes in the precision of S3 cleavage of Notch-1. Mol. Cell. Biol. 28: 165-176.
14. Tsukumo, S., and K. Yasutomo. 2004. Notch governing mature T cell differentiation. J. Immunol. 173: 7109-7113.
15. + T cells. J. Immunol. 182: 3380-3389.
16. Stanley, P., and C. J. Guidos. 2009. Regulation of Notch signaling during T- and B-cell development by O-fucose glycans. Immunol. Rev. 230: 201-215.
17. Ridgway, J., G. Zhang, Y. Wu, S. Stawicki, W. C. Liang, Y. Chanthery, J. Kowalski, R. J. Watts, C. Callahan, I. Kasman, et al. 2006. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444: 1083-1087.
18. Noguera-Troise, I., C. Daly, N. J. Papadopoulos, S. Coetzee, P. Boland, N. W. Gale, H. C. Lin, G. D. Yancopoulos, and G. Thurston. 2006. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444: 1032-1037.
19. Siekmann, A. F., and N. D. Lawson. 2007. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445: 781-784.